Summary
Svelte Medical Systems, Inc. (Svelte) is a medical device company that designs and develops balloon expandable stents. The company’s products include svelte acrobat, balloon expandable stents and drug eluting stent. Its svelte acrobat is a stent-on-a-wire bare metal coronary stent system. Svelte has also developed svelte coronary stent integrated delivery system and balloon control band technologies. The company’s IDS technology is an all-in-one approach to coronary artery stenting allowing for reduced system profile and delivery through smaller access sites to facilitate the transradial approach. It also provides clinical trial services. The company has its presence in Belgium. Svelte is headquartered in Providence, New Jersey, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Svelte Medical Systems, Inc.
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Svelte Medical Systems, Inc. Company Snapshot 5
Svelte Medical Systems, Inc. Company Overview 5
Key Information 5
Svelte Medical Systems, Inc. Pipeline Products and Clinical Trials Overview 6
Svelte Medical Systems, Inc. – Pipeline Analysis Overview 8
Key Facts 8
Svelte Medical Systems, Inc. - Major Products and Services 9
Svelte Medical Systems, Inc. Pipeline Products by Development Stage 10
Svelte Medical Systems, Inc. Pipeline Products Overview 12
Svelte Acrobat System 12
Svelte Acrobat System Product Overview 12
Svelte Drug-Eluting Coronary Stent With IDS 13
Svelte Drug-Eluting Coronary Stent With IDS Product Overview 13
Svelte Drug-Eluting Coronary Stent With Rapid-Exchange Delivery System 14
Svelte Drug-Eluting Coronary Stent With Rapid-Exchange Delivery System Product Overview 14
Svelte Medical Systems, Inc. - Key Competitors 15
Svelte Medical Systems, Inc. - Key Employees 16
Svelte Medical Systems, Inc. - Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Svelte Medical Systems, Inc., Recent Developments 18
Feb 12, 2015: Svelte Medical Systems and ASAHI INTECC Announce Manufacturing and Co-Branding Agreements 18
Sep 18, 2014: World’s First Integrated Delivery System Meets All Endpoints in the Direct II Randomized, Controlled Drug-Eluting Coronary Stent Study 18
May 29, 2014: Svelte Medical Systems Announces Completion of 6-Month Follow-up in the DIRECT II Drug-Eluting Stent Study 19
Nov 14, 2013: Svelte Medical Systems Announces Enrollment Complete in the DIRECT II Drug-Eluting Stent Study 19
May 23, 2013: Svelte Drug-Eluting Stent Utilizing New Class Of Bioabsorbable Drug Coating Attains 0% Clinically-Driven Events Through 12-Months In First-In-Man Study 20
Jan 30, 2013: Svelte Medical Systems Announces Treatment Of First Patient In DIRECT II DES Study 21
Dec 20, 2012: Svelte Medical Systems Announces Treatment Of First Patient In ACES Effectiveness Study 22
Oct 22, 2012: Svelte Medical Systems Announces FDA Approval To Initiate Pivotal Study Of Its Coronary Stent Integrated Delivery System 22
Oct 10, 2012: Svelte Medical Appoints Jack Darby As CEO 23
Jun 14, 2012: Svelte Medical Systems Commences FAASTER Post-Market Registry Study 23
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25
List Of Tables
List of Tables
Svelte Medical Systems, Inc., Key Facts 5
Svelte Medical Systems, Inc. Pipeline Products and Clinical Trials Overview 6
Svelte Medical Systems, Inc. Pipeline Products by Equipment Type 6
Svelte Medical Systems, Inc. Pipeline Products by Indication 7
Svelte Medical Systems, Inc., Key Facts 8
Svelte Medical Systems, Inc., Major Products and Services 9
Svelte Medical Systems, Inc. Number of Pipeline Products by Development Stage 10
Svelte Medical Systems, Inc. Pipeline Products Summary by Development Stage 11
Svelte Acrobat System - Product Status 12
Svelte Acrobat System - Product Description 12
Svelte Drug-Eluting Coronary Stent With IDS - Product Status 13
Svelte Drug-Eluting Coronary Stent With IDS - Product Description 13
Svelte Drug-Eluting Coronary Stent With Rapid-Exchange Delivery System - Product Status 14
Svelte Drug-Eluting Coronary Stent With Rapid-Exchange Delivery System - Product Description 14
Svelte Medical Systems, Inc., Key Employees 16
Svelte Medical Systems, Inc., Other Locations 17
List Of Figures
List of Figures
Svelte Medical Systems, Inc. Pipeline Products by Equipment Type 7
Svelte Medical Systems, Inc. Pipeline Products by Development Stage 10
